Science

AddToAny

Google+ Facebook Twitter Twitter

Recent advances and updates in biomedical science

Deputy Editor Guy Orchard summarises a review paper and looks at planned special issues of the British Journal of Biomedical Science.

With this latest synopsis we focus on infectious disease and more specifically a review paper by AD Blann and R Heitmar, who discuss the viral disease known as COVID-19, caused by SARS-CoV-2. This infection is now the leading cause of death by a single infectious agent worldwide.

The review examines certain components of the pandemic: its origins, early clinical observational data, global and UK-focused epidemiology, vaccination, variants, and the subsequent rise and impact of long COVID.

Click here to read the full article

Image credit | Science-Photo-Library |Getty | Shutterstock | iStock

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top